Effectiveness of dietary protein augmentation associated with angiotensin-converting enzyme inhibition in the management of the nephrotic syndrome.
To determine whether the increase in proteinuria resulting from high dietary protein intake could be prevented by angiotensin-converting enzyme inhibition (ACEI), we performed paired studies on 8 nephrotic patients with normal GFR. They were fed sequential diets with a protein content of 0.8 (LPD) and 1.6 g/kg BW (HPD) each for 8 weeks. Patients on HPD received enalapril (ENAL) 10 mg/day. Despite the significant difference in protein intake, urinary protein excretion, at the end of the two dietary periods, was not statistically different. However, total serum protein and serum albumin increased significantly with HPD + ENAL treatment. The capability of ACEI to prevent the increase in proteinuria induced by HPD may be due to changes in glomerular hemodynamics, possibly mediated by changes in the activity of angiotensin II. Our study indicates that protein metabolism in nephrotic patients is better maintained with HPD + ENAL than with LPD alone.
Garini
G
G
Institute of Clinical Medicine and Nephrology, University of Parma, Italy.
Mazzi
A
A
Allegri
L
L
Buzio
C
C
Borghetti
A
A
D000293:Adolescent; D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001794:Blood Pressure; D001798:Blood Proteins / Q000378:metabolism; D001835:Body Weight; D003404:Creatinine / Q000097:blood; D004044:Dietary Proteins; D004656:Enalapril / Q000627:therapeutic use*; D005260:Female; D005527:Food, Fortified; D006801:Humans; D008297:Male; D009404:Nephrotic Syndrome / Q000503:physiopathology / Q000628:therapy*; D010349:Patient Compliance; D011507:Proteinuria; D012709:Serum Albumin / Q000378:metabolism; D014508:Urea / Q000097:blood
D000806:Angiotensin-Converting Enzyme Inhibitors; D001798:Blood Proteins; D004044:Dietary Proteins; D012709:Serum Albumin; D004656:Enalapril; D014508:Urea; D003404:Creatinine